Device and Method for Centrifuging a Physiological Fluid
20230010728 · 2023-01-12
Inventors
Cpc classification
A61M1/3693
HUMAN NECESSITIES
B01L3/5021
PERFORMING OPERATIONS; TRANSPORTING
A61M1/893
HUMAN NECESSITIES
B01L2200/026
PERFORMING OPERATIONS; TRANSPORTING
International classification
Abstract
A device and associated method for centrifuging a physiological fluid includes a container including a tip, a base, and a barrel extending between the tip and the base to hold a physiological fluid. The container includes a plunger positioned within the barrel of the container. The plunger includes a concave collection surface that faces the tip of the container. A plunger gasket seal is in sealing engagement with an inside wall of the barrel of the container. A bottom support is provided to support the base of the container at least partially within the bottom support for use in a centrifuge. The container is coupled to the bottom support using an interference fit. The collection surface of the plunger and at least the barrel can be made of the same material. Advantageously, the device can be used to process blood without the need for any added anticoagulant in the blood.
Claims
1. A device for centrifuging a physiological fluid, the device comprising: a) a container including a tip, a base, and a barrel extending between the tip and the base to hold a physiological fluid; b) a plunger positioned within the barrel of the container, the plunger including a concave collection surface facing the tip of the container and a gasket seal in sealing engagement with an inside wall of the barrel; and c) a bottom support sized and shaped to support the base of the container at least partially within the bottom support for use in a centrifuge, the container being coupled to the bottom support using an interference fit.
2. The device of claim 1, further comprising a screen positioned in the barrel of the container between the plunger and the tip of the container.
3. The device of claim 1, wherein the bottom support includes a support base having a hole to provide access to the plunger of the container, the hole being threaded to accept a screw mechanism configured to apply a mechanical force to the plunger.
4. The device of claim 1, wherein the collection surface of the plunger and at least the barrel of the container are made of the same material.
5. The device of claim 4, wherein the material is polypropylene.
6. The device of claim 1, further comprising a top support sized and shaped to support the tip of the container at least partially within the top support for use in a centrifuge, the container being coupled to the top support using an interference fit.
7. The device of claim 1, wherein the container tip includes a luer port and wherein the device further comprises a cap to close the luer port.
8. The device of claim 1, wherein the barrel includes at least one protrusion and the bottom support includes at least one recess configured to receive the protrusion, the recess and the protrusion cooperating to provide a snap fit engagement between the container and bottom support when coupled.
9. The device of claim 8, wherein the at least one protrusion of the barrel is cantilevered, and wherein the recess is windowed to allow an external force to be applied to the protrusion to displace the protrusion from the recess, to cause disengagement of the snap fit.
10. The device of claim 1, wherein the plunger includes a rounded top rim encircling the concave surface, a rounded bottom rim, and a sidewall extending between the top rim and bottom rim, the sidewall including an annular recess to hold the gasket seal.
11. A method for centrifuging a physiological fluid, the method comprising: a) holding a physiological fluid in a container, the container including a tip, a base and a barrel extending between the tip and the base, the container including a plunger positioned within the barrel, the plunger including concave collection surface facing the tip of the container and a gasket seal in sealing engagement with an inside wall of the barrel; b) supporting the base of the container at least partially within a bottom support, the container being coupled to the bottom support using an interference fit; and c) centrifuging the physiological fluid in the container supported by the bottom support.
12. The method of claim 11, wherein the collection surface of the plunger and at least the barrel of the container are made of the same material.
13. The method of claim 11, further comprising supporting the tip of the container with a top support at least partially within the top support, the container being coupled to the top support using an interference fit, and wherein the physiological fluid is centrifuged in the container supported by the top and bottom and supports.
14. The method of claim 11, wherein the physiological fluid is centrifuged in a first centrifugation with the base of the container away from a center of a centrifuge rotor.
15. The method of claim 14, further comprising extracting a first fraction of the physiological fluid from the container after the first centrifugation.
16. The method of claim 15, wherein a portion of the physiological fluid is further centrifuged in a second centrifugation with the tip of the container away from a center of a centrifuge rotor.
17. The method of claim 16, further comprising extracting second and third fractions of the physiological fluid from the container after the second centrifugation.
18. The method of claim 17, wherein the physiological fluid is adipose aspirate, the first fraction is a lipid layer, the second fraction is infranatant, and the third fraction is adipose graft tissue.
19. The method of claim 16, wherein the container tip includes a luer port and wherein the method further comprises closing the luer port with a cap prior to the second centrifugation.
20. The method of claim 15, further comprising: a) transferring the first fraction of the physiological fluid to a second container, the second container including a tip, a base and a barrel extending between the tip and the base, the second container including a plunger positioned within the barrel, the plunger including a concave collection surface facing the tip of the second container and a gasket seal in sealing engagement with an inside wall of the barrel; and b) in a second centrifugation, centrifuging the first fraction of the physiological fluid in the second container supported by a second bottom support.
21. The method of claim 20, further comprising extracting second and third fractions of the physiological fluid from the second container after the second centrifugation.
22. The method of claim 21, wherein the physiological fluid is blood, the first fraction is plasma, the second fraction is platelet poor plasma (PPP), and the third fraction is platelet rich plasma (PRP).
23. The method of claim 11, wherein the physiological fluid is blood, and wherein the blood is centrifuged without adding anticoagulant to the blood prior to centrifugation.
24. The method of claim 11, further comprising positioning a screen in the barrel of the container between the plunger and the tip of the container.
25. The method of claim 11, wherein the bottom support includes a support base having a hole to provide access to the plunger of the container, and further comprising applying a mechanical force to the plunger with a screw mechanism threaded through the hole, the applied mechanical force assisting in extracting a fraction of the physiological fluid from the container.
26. A method for centrifuging a physiological fluid using the device of claim 1, the method comprising: a) loading the physiological fluid into the container of the device; and b) centrifuging the physiological fluid in the container supported by the bottom support of the device.
27. The method of claim 26, wherein the physiological fluid is blood, and wherein the blood is centrifuged without adding anticoagulant to the blood prior to centrifugation.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0036] The foregoing will be apparent from the following more particular description of example embodiments, as illustrated in the accompanying drawings in which like reference characters refer to the same parts throughout the different views. The drawings are not necessarily to scale, emphasis instead being placed upon illustrating embodiments.
[0037]
[0038]
[0039]
[0040]
[0041]
[0042]
[0043]
[0044]
[0045]
[0046]
[0047]
[0048]
[0049]
[0050]
[0051]
[0052]
[0053]
[0054]
[0055]
[0056]
[0057]
[0058]
[0059]
[0060]
[0061]
[0062]
[0063]
[0064]
[0065]
DETAILED DESCRIPTION
[0066] A description of example embodiments follows.
[0067] The device described herein is an improvement over the device described in International Application No. PCT/US2018/063317, entitled “Apparatus And Method For Centrifuging a Biologic,” filed on Nov. 30, 2019 and published Jun. 6, 2019 as WO 2019/108937, the teachings of which are incorporated herein by reference in their entirety.
[0068]
[0069] The tip 104 of the container 102 can include or otherwise incorporate a luer connector. As illustrated, a luer lock valve 130 can be coupled to the tip 104 of the container to allow for controlled fluid transfer into and out of the container. The valve 130 can provide a swabable valve port 132 (see, e.g.,
[0070] The device and its components, as illustrated in
[0071] 1) The plunger 110, which is movably positioned in the barrel 108 of the container, has a concave surface 112 that facilitates the collection of target cells after centrifugation.
[0072] 2) The thickness of the walls of the barrel 108 can be 2 mm or greater. The wall thickness provides strength and rigidity to the container, reducing the risk that the container wall will deform under high g-force loads during centrifugation.
[0073] 3) The barrel 108 and the plunger 110 can be made of polypropylene.
[0074] 4) The seal 114 of the plunger can be in the form of a gasket, which can be an O-ring or an X-ring. An X-ring gasket is a standard part and known in industry. There can be more than one gasket, e.g. two gaskets as illustrated in
[0075] 5) A screen 120 (
[0076] 6) A bottom support structure 116 can be press fit over the bottom of the container barrel 108. As illustrated, at least a portion of the bottom support structure 116 encompasses the entire 360 degrees of the circular circumference of the barrel 108.
[0077] 7) As illustrated in
[0078] 8) A top support structure 118 (
[0079] 9) The bottom and top support structures allow the assembled device 100 to be centrifuged in either orientation, luer tip up or luer tip down.
[0080] A user can load fluid into the vessel, e.g., the vial or container 102, through the luer tip 104 and past the screen 120 that is press fit in place. The user can centrifuge the fluid material in the vessel in either direction, luer up or luer down. The support structures (116, 118) absorb the forces of centrifugation to prevent the assembly from breaking or leaking. The fluid can be evacuated from the barrel of the container through the screen using the luer connection. Additional force can be applied to the plunger 110 by using the screw feature 200 (
[0081] As illustrated in
[0082] As illustrated in
[0083] The screen 120 can serve two functions. It can force laminar flow during extraction of the separated layers (e.g., separated fractions) after centrifugation. Laminar flow can reduce or prevent mixing of the separated layers. This enables removal of different density layers to capture high density fat. In addition, the screen serves as sieve, prevent larger particles, e.g., larger adipose particles from exiting the container. This can reduce or prevent clogging of the container tip, e.g., during extraction from the container. Embodiments provide a closed system that allows for removal of excess lipids and blood with a screen and a mechanical assist fluid transfer feature that micronizes the adipose graft for easy application. The system is considered closed because there is not vent and no port other than at the luer tip. The port at the luer tip can be capped, as further described herein.
[0084]
[0085] The plunger's concave surface 112 forms a central depression 152. The depth of the central depression can be less than the width and/or the diameter of the plunger. For example, the depth of the central depression 152 can be 0.080 inches and the diameter of the plunger can be 0.141 inches.
[0086] As illustrated in
[0087]
[0088] Further details regarding the use of the device, including additional figures, are provide in the Examples below, which illustrate additional views and alternative embodiments.
EXEMPLIFICATION
Example 1—Processing Adipose Aspirate
[0089]
[0090] Step 1 (
[0091] Fill container 102 of device 100 with 30-40 cc of adipose aspirate.
[0092] Place device 100 into centrifuge (swingout rotor bucket). Use a counter-balance or an additional disposable device to balance the centrifuge.
[0093] Swab port valve 130 (to remove any residual blood/aspirate).
[0094] Centrifuge at 3200 RPM for 2 minutes.
[0095] Step 2 (
[0096] Remove device 100 from the centrifuge bucket and swab port valve 130.
[0097] Decant lipid layer 305 to a syringe. Stop decanting lipid layer 305 when adipose graft 310 interface enters the neck of luer tip below port valve 130, leaving the adipose graft 310 and infranatant 315 in container.
[0098] Step 3 (
[0099] Attach a locking cap 320 to port valve 130.
[0100] Place device 100 in rotor bucket (luer tip down). Use a counter-balance or an additional disposable device to balance the centrifuge.
[0101] Centrifuge at 3200 RPM for 1 minute.
[0102] Step 4 (
[0103] Remove device 100 from centrifuge bucket.
[0104] Remove cap 320.
[0105] Decant infranatant 315 with a syringe. Stop decanting infranatant when the adipose graft 310 appears in neck of valve 130.
[0106] Step 5 (
[0107] Connect collection syringe 350 to leer valve 130 and connect mechanical assist device 200 to bottom support 116.
[0108] Transfer the adipose graft 310 from the container 102 to the syringe 350 using threaded assist device 200. The screw 202 of device 200 contacts and pushes the plunger 110, to extract the adipose graft. If a screen 120 is present in the container, the adipose grab is filtered through the screen.
Example 2—Processing Blood
[0109]
[0110] The plunger's platelet collection surface allows for maximum volume reduction, lowest hematocrit, highest platelet recovery, and highest increase over baseline, all in an easy to use and disposable closed system.
[0111] As illustrated in
[0112]
[0113]
[0114] Step 1 (
[0115] Fill container of device 400a with 30 cc of blood. The blood may be anti-coagulated but need not be.
[0116] Place device 400a into a centrifuge (swingout rotor bucket) and use counterweight or additional disposable device with equal weight.
[0117] Swab port valve 130 (to remove any residual blood).
[0118] Centrifuge at 3200 RPM for 2 minutes.
[0119] Step 2 (
[0120] Remove device 400a from centrifuge bucket and swab port valve 130.
[0121] Decant cloudy plasma 515 to syringe 550b.
[0122] Stop decanting plasma when red blood cell (RBC) interface, e.g., infranatant 510, enters neck of luer tip of the container.
[0123] Step 3 (
[0124] Load second device 400b with cloudy plasma 515 from syringe 550b. Optionally, add 2 ml anti-coagulant to the second device 400b prior to loading the plasma.
[0125] Place second device 400b into centrifuge (swingout rotor bucket) and use counterweight or additional disposable device with equal weight.
[0126] Swab port valve 130.
[0127] Centrifuge at 3200 RPM for 6 minutes.
[0128] Step 4 (
[0129] Remove device 400b from the centrifuge bucket. Platelets, of platelet rich plasma 520, are expected to be visible on collection surface of the plunger.
[0130] Decant upper, clear plasma 525 with syringe 550c. Stop decanting plasma at desired level as PRP collection surface of plunger approaches the top of the device 400b.
[0131] Step 5 (
[0132] Decant remaining plasma and platelets, e.g., platelet rich plasma 520, with syringe 520d, flushing back and forth to resuspend platelets as needed. As exemplified by syringe 550d, the syringe includes a male luer port 552, which can couple to port valve 130, thereby allowing for needleless transfer of fluid. The needless design is a feature of all devices and syringes described herein, including devices 100, 400, and 400a-b, and syringes 350, 450, and 550a-d.
Example 3—Processing Blood, Single Spin
[0133]
[0134]
[0135] STEP 1: Load blood 705, optionally anticoagulated, into the device 400 (CPD-1).
[0136] STEP 2: Process blood into components infranatant 710, platelet rich plasma (PRP) 720, and platelet poor plasma (PPP) 725 by centrifuging at 1900 g for 6 minutes. Extract PPP 725 using a syringe.
[0137] STEP 3: Extract PRP 720 using a syringe.
Example 4—Processing Blood, Double Spin
[0138]
[0139]
[0140] STEP 1: Load blood 905, optionally anticoagulated, into the first device 400a (CPD-1).
[0141] STEP 2: Process blood into components infranatant 910, and cloudy plasma 915 by centrifuging at 1900 g for 2 minutes. Extract plasma 915 using a syringe.
[0142] STEP 3: Load plasma 915 into the second device 400b (CPD-2). Process by centrifuging at 1900 g for 5 minutes.
[0143] STEP 4: Extract platelet poor plasma (PPP) 925 above platelet rich plasma (PRP) 920 from second device using a syringe.
[0144] STEP 5: Extract PRP 920 using a syringe.
Example 5—Processing Blood, Double Spin
[0145]
[0146]
[0147] STEP 1: Load blood 1105, optionally anticoagulated, into each of the first devices 400a (CPD-1).
[0148] STEP 2: Process blood into components infranatant 1110 and cloudy plasma 1115 by centrifuging at 3200 RPM for 2 minutes (in standard centrifuge). Extract plasma 1115 from each device using one or more syringes.
[0149] STEP 3: Load plasma 1115 from each of the first devices into the second device 400b (CPD-2). Process by centrifuging at 3200 RPM for 5 minutes (in standard centrifuge).
[0150] STEP 4: Extract platelet poor plasma (PPP) 1125 above platelet rich plasma (PRP) 1120 from the second device using a syringe.
[0151] STEP 5: Extract PRP 1120 from the second device using a syringe.
[0152] Prior approaches to centrifuging physiological fluids have used a funnel-shaped insert positioned in a centrifugation container to separate cell fractions. Embodiments of the present invention do not require such an insert. Examples of prior approaches using inserts are described in the following published applications, the teachings of which are incorporated herein by reference in their entirety:
[0153] Cell separation methods and apparatus are described in International Application No. PCT/US2006/042237, filed on Oct. 27, 2006 and published on May 3, 2007 as WO2007/050986 A1. Cell concentration devices and methods are described in International Application No. PCT/US2014/013636, filed on Jan. 29, 2014 and published on Aug. 7, 2015 as WO2014/120797 A1. Apparatus and methods for aspirating and separating components of different densities from a physiological fluid containing cells are described in International Application No. PCT/US2010/036696, filed on May 28, 2010 and published on Dec. 2, 2010 as WO2010/138895 A2.
[0154] Physiological fluids, such as bone marrow, can be aspirated using double-cannula needle assemblies. Examples of such approaches are described in the following patent applications, the teachings of which are incorporated herein by reference in their entirety:
[0155] Apparatus and methods for aspirating and separating components of different densities from a physiological fluid containing cells are described in International Application No. PCT/US2010/036696, filed on May 28, 2010 and published on Dec. 2, 2010 as WO2010/138895 A2. Apparatus and methods for aspirating tissue are described in International Application No. PCT/US2013/067358, filed on Oct. 29, 2013 and published on May 8, 2014 as WO2014/070804 A1. An aspiration device and associated method including an introducer needle assembly, an aspiration needle assembly and a screw assembly are described in International Application No.: PCT/US2015/011614, filed on Jan. 15, 2015 and published on Jul. 23, 2015 as WO2015/109100 A1. An aspiration device and method including an introducer cannula, an aspiration cannula and a mechanism (e.g., a screw assembly) to move the cannulae are described in U.S. application Ser. No. 14/885,821, filed on Oct. 16, 2015 and published on Apr. 21, 2016 as US 2016/0106462 A1.
[0156] The teachings of all patents, published applications and references cited herein are incorporated by reference in their entirety.
[0157] While example embodiments have been particularly shown and described, it will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the scope of the embodiments encompassed by the appended claims.